About the Phase 2 Trial. This global phase 2 trial is evaluating the efficacy and safety of two doses (8 mg/kg or 12 mg/kg) of DS-7300 in patients with histologically or cytologically confirmed ...

In 2017, DS-1211 was tested in Phase 1 clinical trials of healthy volunteers. The Phase 2 study will test dosing, safety and pharmacological properties of the investigational drug in individuals ...

Phase 1/2 Trial Initiated for Daiichi Sankyo’s Menin Inhibitor DS-1594 in Patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia April 07, 2021 08:00 AM Eastern Daylight Time ...